FDA Enforcement
Class II
Ongoing
Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for pain therapy, Model Number CT900C
Recall: Z-0913-2023
·
Reported January 18, 2023
Enforcement
- Recall Number
- Z-0913-2023
- Event ID
- 91296
- Classification
- Class II
- Status
- Ongoing
- Product Type
- Devices
- Firm
- Medtronic Neuromodulation
- Voluntary / Mandated
- Voluntary: Firm initiated
- Initial Notification
- Letter
- Report Date
- January 18, 2023
- Initiation Date
- December 3, 2022
- Classification Date
- January 6, 2023
- Address
- 7000 Central Ave Ne, Minneapolis, MN, 55432-3568, United States
Description
Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for pain therapy, Model Number CT900C
Reason
Software anomalies, CP App messages: "Too Many Device Found", "Unexpected Device Error Code 1502", and "System Update Needed, Service Code 303"
Code Info
GTIN 00643169890961: Lot/Serial Numbers: NPL1000794, NPL1002295, NPL1002284, NPL1002272, NPL1001670, NPL1001615, NPL1001596, NPL1001588, NPL1001591, NPL1001592, NPL1001583, NPL1001579, NPL1001558, NPL1000777, NPL1000774, NPL1000776, NPL1000453, NPL1000429,
Distribution
Worldwide distribution.
Quantity
18 units